Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ESCAPE Bio, Inc.Startup |
Active Organization- |
Inactive Organization ESCAPE Bio, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | ESCAPE Bio, Inc.Startup | 13 Jan 2019 |